BDO Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.02M | Buy |
2,816
+28
| +1% | +$20.1K | 0.23% | 90 |
|
|
2023
Q1 | $2.29M | Sell |
2,788
-74
| -3% | -$60.8K | 0.28% | 77 |
|
|
2022
Q4 | $2.06M | Sell |
2,862
-42
| -1% | -$30.3K | 0.26% | 85 |
|
|
2022
Q3 | $2M | Sell |
2,904
-147
| -5% | -$101K | 0.27% | 80 |
|
|
2022
Q2 | $1.8M | Sell |
3,051
-4
| -0.1% | -$2.37K | 0.22% | 88 |
|
|
2022
Q1 | $2.13M | Buy |
3,055
+87
| +3% | +$60.8K | 0.23% | 83 |
|
|
2021
Q4 | $1.87M | Buy |
2,968
+137
| +5% | +$86.5K | 0.2% | 89 |
|
|
2021
Q3 | $1.71M | Buy |
2,831
+80
| +3% | +$48.4K | 0.19% | 90 |
|
|
2021
Q2 | $1.54M | Buy |
2,751
+2,554
| +1,296% | +$1.43M | 0.17% | 104 |
|
|
2021
Q1 | $93K | Buy |
197
+190
| +2,714% | +$89.7K | 0.01% | 364 |
|
|
2020
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 725 |
|
|
2020
Q3 | $4K | Buy |
+7
| New | +$4K | ﹤0.01% | 596 |
|
|
2019
Q1 | – | Sell |
-50
| Closed | -$19K | – | 652 |
|
|
2018
Q4 | $19K | Hold |
50
| – | – | 0.01% | 352 |
|
|
2018
Q3 | $20K | Hold |
50
| – | – | 0.01% | 383 |
|
|
2018
Q2 | $17K | Buy |
+50
| New | +$17K | 0.01% | 400 |
|
|
2017
Q3 | – | Sell |
-50
| Closed | -$25K | – | 526 |
|
|
2017
Q2 | $25K | Buy |
+50
| New | +$25K | 0.01% | 286 |
|